Paralytic Poliomyelitis - United States, 1980-1994

Morbidity and Mortality Weekly Report

Volumn 46, Issue 4, 1997, Pages 79-83

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

ARTICLE; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; POLIOMYELITIS; RISK; STANDARD; UNITED STATES; VACCINATION;

HUMANS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; POLIOMYELITIS; POLIOVIRUS VACCINE, INACTIVATED; POLIOVIRUS VACCINE, ORAL; RISK; UNITED STATES; VACCINATION;

EID: 0031592417     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. ACIP. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine - recommendations of the Advisory Committee on Immunization Practices. MMWR 1997;46(no. RR-3).
2. CDC. Poliomyelitis - United States, 1975-1984. MMWR 1986;35:180-2.
3. CDC. Certification of poliomyelitis eradication - the Americas, 1994. MMWR 1994;43:720-2.
4. Miller MA, Sutter RW, Strebel PM, Hadler SC. Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule. JAMA 1996;276:967-71.
5. Prevots DR, Sutter RW, Quick L, Izurieta H, Strebel PM. Vaccine-associated paralytic poliomyelitis in the United States, 1980-1994: current risk and potential impact of proposed sequential schedule of IPV followed by OPV [Abstract]. In: Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, Louisiana: American Society for Microbiology, 1996:179.
6. Prevots DR, Sutter RW, Strebel PM, Weibel RE, Cochi SL. Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991: implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med 1994;148:479-85.
7. Strebel PM, Sutter RW, Cochi SL, et al. Epidemiology of poliomyelitis in lhe United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis 1992;14:568-79.
8. Orenstein WA, Wassilak SGF, Deforest A, et al. Seroprevalence of poliovirus antibodies among Massachusetts schoolchildren. In: Program and abstracts of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy [Abstract]. Washington, DC: American Society for Microbiology, 1988:198.
9. Kelley PW, Petruccelli BP, Stehr-Green P, Erickson RL, Mason CJ. The susceptibility of young adult Americans to vaccine-preventable infections: a national serosurvey of US Army recruits. JAMA 1991;266:2724-9.
10. CDC. Mandatory reporting of infectious diseases by clinicians. MMWR 1990;39(no.RR-9):1-17.